Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Recovery of Gonadal Hormone Level Is a Potential Marker for the Response and Prognosis in POEMS Syndrome Patients Treated with Bortezomib Based Combined Chemotherapy

Fang Fang, Guoxiang Wang, Ronghua Hu, Wuhan Hui, Hong Zhao, Yixian Guo, Bingxin Ji, Li Su, Wanling Sun

Blood (2021) 138 (Supplement 1): 4741.

https://doi.org/10.1182/blood-2021-152109

Published: 2021

Journal Articles

Ibrutinib in Combination with Rituximab and High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients

Yixian Guo, Xiaoxi Lan, Xiaoli Chang, Guoxiang Wang, Dongmei Zou, Li Su, Wanling Sun

Blood (2021) 138 (Supplement 1): 1416.

https://doi.org/10.1182/blood-2021-147742

Published: 2021

Journal Articles

Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome

Blood (2016) 128 (22): 5536.

https://doi.org/10.1182/blood.V128.22.5536.5536

Published: 2016

Journal Articles

Alterations of Signaling Pathways in Essential Thrombocythemia with Calreticulin Mutation

Wuhan Hui, PhD, Fei Ye, Wei Zhang, Congyan Liu, Suigui Wan, Li Su

Blood (2016) 128 (22): 4286.

https://doi.org/10.1182/blood.V128.22.4286.4286

Published: 2016

Journal Articles

Prognosticating of Relapse Risk Based on Multiparameter Flow Cytomeric Assessment of Minimal Residual Disease in Patients with Acute Myeloid Leukemia

Suigui Wan, MD, Lugui Qiu, MD, Xuejing Sun, Hong Zhao, MD, Li Su, MD, Juan Xu, MD

Blood (2008) 112 (11): 3974.

https://doi.org/10.1182/blood.V112.11.3974.3974

Published: 2008

Journal Articles

Long Term Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Progressive Multiple Sclerosis

Juan Xu, Tong Wu, Li Su, Bing Xin Ji, Wu Han Hui

Blood (2008) 112 (11): 4438.

https://doi.org/10.1182/blood.V112.11.4438.4438

Published: 2008

NARROW

Recovery of Gonadal Hormone Level Is a Potential Marker for the Response and Prognosis in POEMS Syndrome Patients Treated with Bortezomib Based Combined Chemotherapy

Ibrutinib in Combination with Rituximab and High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients

Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome

Alterations of Signaling Pathways in Essential Thrombocythemia with Calreticulin Mutation

Prognosticating of Relapse Risk Based on Multiparameter Flow Cytomeric Assessment of Minimal Residual Disease in Patients with Acute Myeloid Leukemia

Long Term Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Progressive Multiple Sclerosis

Email alerts

ASH Publications

American Society of Hematology

Recovery of Gonadal Hormone Level Is a Potential Marker for the Response and Prognosis in POEMS Syndrome Patients Treated with Bortezomib Based Combined Chemotherapy

Ibrutinib in Combination with Rituximab and High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients

Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome

Alterations of Signaling Pathways in Essential Thrombocythemia with Calreticulin Mutation

Prognosticating of Relapse Risk Based on Multiparameter Flow Cytomeric Assessment of Minimal Residual Disease in Patients with Acute Myeloid Leukemia

Long Term Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Progressive Multiple Sclerosis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only